Literature DB >> 32239578

Priorities for global health community in COVID-19 pandemic.

Lidia Rudnicka1, Mrinal Gupta2, Martin Kassir3, Mohammad Jafferany4, Torello Lotti5, Roxanna Sadoughifar6,7, Mohamad Goldust6,8,9.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32239578      PMCID: PMC7228380          DOI: 10.1111/dth.13361

Source DB:  PubMed          Journal:  Dermatol Ther        ISSN: 1396-0296            Impact factor:   2.851


× No keyword cloud information.
Dear Editor, The novel coronavirus (COVID‐19) has been declared a pandemic by the World Health Organization (WHO), with more than 13 000 deaths in more than 130 countries all across the globe till March 23, 2020. The global health community has to take action to slow its continued spread and reduce the ever increasing mortality. The action needs to be multipronged requiring financial, legislative, and executive action that will require participation from all segments of the society including the government and the citizens [1, 2]. Health care institutions and policy makers developed various plans during the severe acute respiratory syndrome (SARS) epidemic in 2003 and H5N1 epidemic of 2005, which can be refined and utilized in this pandemic. These plans mainly addressed the issues of protection of health care professionals, the sudden surge in patient numbers, and patient management with limited resources [3]. The foremost priority for the health community will be preparation of the hospitals and the clinics for the sudden high‐volume patient inflow that will require preparing protocols for triaging and segregating patients in the emergency departments so that COVID‐19 patients do not mix with the “regular” patients and transmit the infection. Prevention of nosocomial infection should be another priority that was a major issue in China [4]. This will require framing of specialized protocols and training of the medical staff and adequate supply of personal protective equipment. Proper availability, utilization, and maintenance of ventilators, as well as simplified protocols for nonexpert physicians should be yet another priority for the health community that can be difficult in the developing world [5]. The physicians treating the patients in all parts of the world also need to keep aware of any recent advancement in therapeutic options. With thousands of health care workers infected with SARS‐CoV‐2 and multiple reported deaths of physicians, an important issue remains the development of procedures for a proper protection of health care workers at any level of patient care, not only for management of confirmed infections. Another major area of concern is the availability of diagnostic testing facilities, which are needed in large numbers and at the point of care. Public health experts need to expand testing to all patients who have unexplained acute respiratory distress syndrome or severe pneumonia, and ultimately to patients who have mild symptoms. An important goal of the global health community is to diminish the spread and flatten the peak of the epidemic curve. To achieve this goal, it becomes imperative for the authorities to educate the public regarding the various aspects of disease transmission which needs to be done quickly to confront the disease.

CONFLICT OF INTEREST

The authors declare no potential conflict of interest.
  6 in total

1.  Coronavirus Infections-More Than Just the Common Cold.

Authors:  Catharine I Paules; Hilary D Marston; Anthony S Fauci
Journal:  JAMA       Date:  2020-02-25       Impact factor: 56.272

2.  Priorities for global health community in COVID-19 pandemic.

Authors:  Lidia Rudnicka; Mrinal Gupta; Martin Kassir; Mohammad Jafferany; Torello Lotti; Roxanna Sadoughifar; Mohamad Goldust
Journal:  Dermatol Ther       Date:  2020-04-08       Impact factor: 2.851

3.  COVID-19: towards controlling of a pandemic.

Authors:  Juliet Bedford; Delia Enria; Johan Giesecke; David L Heymann; Chikwe Ihekweazu; Gary Kobinger; H Clifford Lane; Ziad Memish; Myoung-Don Oh; Amadou Alpha Sall; Anne Schuchat; Kumnuan Ungchusak; Lothar H Wieler
Journal:  Lancet       Date:  2020-03-17       Impact factor: 79.321

4.  Health security capacities in the context of COVID-19 outbreak: an analysis of International Health Regulations annual report data from 182 countries.

Authors:  Nirmal Kandel; Stella Chungong; Abbas Omaar; Jun Xing
Journal:  Lancet       Date:  2020-03-18       Impact factor: 79.321

5.  COVID-19: Vulnerability and the power of privilege in a pandemic.

Authors:  James A Smith; Jenni Judd
Journal:  Health Promot J Austr       Date:  2020-03-20

6.  Eleven faces of coronavirus disease 2019.

Authors:  Xiang Dong; Yi-Yuan Cao; Xiao-Xia Lu; Jin-Jin Zhang; Hui Du; You-Qin Yan; Cezmi A Akdis; Ya-Dong Gao
Journal:  Allergy       Date:  2020-04-06       Impact factor: 14.710

  6 in total
  24 in total

1.  Dermatologic treatments in the era of COVID-19 pandemic-Data and Hypothesis.

Authors:  Roxanna Sadoughifar; Mohamad Goldust; George Kroumpouzos; Jacek C Szepietowski; Torello Lotti; Sunmeet Sandhu
Journal:  Dermatol Ther       Date:  2020-05-26       Impact factor: 2.851

2.  Priorities for global health community in COVID-19 pandemic.

Authors:  Lidia Rudnicka; Mrinal Gupta; Martin Kassir; Mohammad Jafferany; Torello Lotti; Roxanna Sadoughifar; Mohamad Goldust
Journal:  Dermatol Ther       Date:  2020-04-08       Impact factor: 2.851

3.  Mental health status of dermatologists during the COVID-19 pandemic: A technology-based therapy.

Authors:  Mohamad Goldust; Komal Agarwal; George Kroumpouzos; Mohammad Jafferany; Torello Lotti; Indrashis Podder
Journal:  Dermatol Ther       Date:  2020-06-19       Impact factor: 3.858

4.  Evaluation of the effects of COVID-19 pandemic on hair diseases through a web-based questionnaire.

Authors:  Dursun Turkmen; Nihal Altunisik; Serpil Sener; Cemil Colak
Journal:  Dermatol Ther       Date:  2020-07-16       Impact factor: 3.858

5.  Shifting dermatology market strategies from cosmetics to moisturizers and sanitizers treatments in COVID-19 era.

Authors:  Robert A Schwartz; Swetalina Pradhan; Hassan Galadari; Torello Lotti; Aseem Sharma; Mohamad Goldust
Journal:  Dermatol Ther       Date:  2020-07-07       Impact factor: 3.858

6.  COVID 19 and its impact on cosmetic dermatology.

Authors:  Hassan Galadari; Atula Gupta; George Kroumpouzos; Martin Kassir; Lidia Rudnicka; Torello Lotti; Roberta Vasconcelos Berg; Mohamad Goldust
Journal:  Dermatol Ther       Date:  2020-07-01       Impact factor: 3.858

Review 7.  Psoriatic arthritis and COVID-19 pandemic: Consequences in medical treatment?

Authors:  Uwe Wollina; Massimo Fioranelli; Mohamad Goldust; Torello Lotti
Journal:  Dermatol Ther       Date:  2020-06-30       Impact factor: 3.858

8.  The explosion in scabies cases during COVID-19 pandemic.

Authors:  Ömer Kutlu; Habibullah Aktaş
Journal:  Dermatol Ther       Date:  2020-06-11       Impact factor: 3.858

9.  Update on COVID-19 effects in dermatology specialty.

Authors:  Mohamad Goldust; George Kroumpouzos; Dedee F Murrell; Lidia Rudnicka; Anupam Das; Torello Lotti; Alexander A Navarini
Journal:  Dermatol Ther       Date:  2020-06-26       Impact factor: 3.858

Review 10.  Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms.

Authors:  Paulo Ricardo Criado; Beatrice Martinez Zugaib Abdalla; Isabelle Carvalho de Assis; Cristina van Blarcum de Graaff Mello; Gabriela Cacciolari Caputo; Ingrid Campos Vieira
Journal:  Inflamm Res       Date:  2020-06-02       Impact factor: 6.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.